ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Sinclair Pharma Management Limited

Sinclair Pharma Management Limited is an active company incorporated on 22 July 2014 with the registered office located in London, Greater London. Sinclair Pharma Management Limited was registered 11 years ago.
Status
Active
Active since incorporation
Company No
09142486
Private limited company
Age
11 years
Incorporated 22 July 2014
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 22 July 2025 (4 months ago)
Next confirmation dated 22 July 2026
Due by 5 August 2026 (8 months remaining)
Last change occurred 4 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Audit Exemption Subsidiary
Next accounts for period 31 December 2025
Due by 30 September 2026 (9 months remaining)
Address
1st Floor Whitfield Court
30-32 Whitfield Street
London
W1T 2RQ
Same address for the past 5 years
Telephone
02074676920
Email
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Chief Operating Officer • Israeli • Lives in England • Born in Feb 1977
Director • American • Lives in United States • Born in Mar 1969
Sinclair Pharma Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Sinclair Pharmaceuticals Limited
Shalom Haim Cohen and Ryan Andrew Irvine are mutual people.
Active
Is Pharma Ltd
Shalom Haim Cohen and Ryan Andrew Irvine are mutual people.
Active
Sinclair Pharma Holdings Limited
Shalom Haim Cohen and Ryan Andrew Irvine are mutual people.
Active
Is Pharmaceuticals Limited
Ryan Andrew Irvine is a mutual person.
Active
Acorus Therapeutics Limited
Ryan Andrew Irvine is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£134.57M
Same as previous period
Total Liabilities
£0
Same as previous period
Net Assets
£134.57M
Same as previous period
Debt Ratio (%)
0%
Same as previous period
Latest Activity
Jining Liu Resigned
1 Month Ago on 28 Oct 2025
Ryan Andrew Irvine Appointed
1 Month Ago on 28 Oct 2025
Mr Shalom Haim Cohen Appointed
2 Months Ago on 10 Sep 2025
Confirmation Submitted
4 Months Ago on 31 Jul 2025
Amber Rebecca Edwards Resigned
5 Months Ago on 30 Jun 2025
Subsidiary Accounts Submitted
5 Months Ago on 23 Jun 2025
Lucy Jane Benson Resigned
8 Months Ago on 25 Mar 2025
Jayne Katherine Burrell Resigned
12 Months Ago on 9 Dec 2024
Mr Jining Liu Appointed
12 Months Ago on 9 Dec 2024
Ms Amber Rebecca Edwards Appointed
1 Year 2 Months Ago on 30 Sep 2024
Get Credit Report
Discover Sinclair Pharma Management Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Termination of appointment of Jining Liu as a director on 28 October 2025
Submitted on 11 Nov 2025
Appointment of Ryan Andrew Irvine as a director on 28 October 2025
Submitted on 11 Nov 2025
Appointment of Mr Shalom Haim Cohen as a director on 10 September 2025
Submitted on 19 Sep 2025
Confirmation statement made on 22 July 2025 with no updates
Submitted on 31 Jul 2025
Termination of appointment of Amber Rebecca Edwards as a director on 30 June 2025
Submitted on 14 Jul 2025
Audit exemption statement of guarantee by parent company for period ending 31/12/24
Submitted on 23 Jun 2025
Consolidated accounts of parent company for subsidiary company period ending 31/12/24
Submitted on 23 Jun 2025
Audit exemption subsidiary accounts made up to 31 December 2024
Submitted on 23 Jun 2025
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
Submitted on 23 Jun 2025
Termination of appointment of Lucy Jane Benson as a secretary on 25 March 2025
Submitted on 25 Mar 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year